Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
COI prioritise funding support to the current crisis caused by novel coronavirus
Latest News
COI Group Leader Dr Peter Wing Collaborates on ARIA-funded Project to Develop ‘smart’ DNA Medicines
22 Jul, 2026
Dr Peter Wing, Group Leader at the CAMS Oxford Institute (COI), is a collaborator on a four-year research project that aims to develop programmable ‘smart’ DNA medicines capable of activating the body’s early immune defences when a respiratory infection is detected.
Researchers from the University of Oxford and CAMS PUMC gather for CAMS Oxford Institute Symposium 2026
21 Jul, 2026
The CAMS Oxford Institute (COI) Symposium 2026 brought together more than 100 researchers, clinicians and postgraduate students from the University of Oxford and the Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS PUMC) during a three-day programme held at the University of Oxford from 10–12 June.
CSC - CAMS/PUMC - Oxford High-level Innovative Talent Scholarships
The Chinese Scholarship Council, Chinese Academy of Medical Sciences/Peking Union Medical College and the University of Oxford collaborate together for a programme of scholarship cooperation.
The main purpose of this programme is to train the next generation of leaders in the medical sciences field. By combining the strength of our partners, it is aimed at students with a clinical background with an interest in pursuing research in a scientific field related to medicine.
Key COVID-19 Publications
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Journal article
Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
Journal article
Liu C. et al, (2022), Cell Host & Microbe, 30, 53 - 68.e12
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Journal article
Flaxman A. et al, (2021), The Lancet, 398, 981 - 990
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Journal article
Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Journal article
Townsend A. et al, (2020)
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Journal article
Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Journal article
Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Journal article
Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Journal article
Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345
Current Vacancies
There are currently no vacancies in COI.